EP03.01-003 Clinical Features and Molecular Profile of Advanced Non-small Cell Lung Cancer in Latin America: LATINO Lung (LACOG 0116)

01/09/2022

Abstracts, Publications, Publications Lung

G. Werutsky, O. Arrieta, M. Zukin, C. Mathias, A.C.Z. Gelatti, D.L. Kaen, A.F. Cardona, E. Cronemberg, C. Campos, L.H. Araújo, H. de Andrade, S.L. Reichow, V.C. de Lima, P. Pacheco, J.C. Coelho, G. Borges, A. Silva, E. Mascarenhas, A. Quiroga, L. Fein, F.N.G. de Oliveira, J. Pastorello, C. Dutra, I. Morbeck, F.S.M. Cruz, T.F. Rebelatto, R. Gomes, C.H. Barrios

DOI: 10.1016/j.jtho.2022.07.398

Full link: https://www.sciencedirect.com/science/article/abs/pii/S1556086422007390

EP03.01-003 Clinical Features and Molecular Profile of Advanced Non-small Cell Lung Cancer in Latin America: LATINO Lung (LACOG 0116)

Send us a message

Cura Project

EP03.01-003 Clinical Features and Molecular Profile of Advanced Non-small Cell Lung Cancer in Latin America: LATINO Lung (LACOG 0116)

Related Posts

In reply to Li et al. Letter to the editor. “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials.”

Moderately hypofractionated post-operative radiation therapy for breast cancer: Preferences amongst radiation oncologists from countries in Latin America and the Caribbean

TP040/#1418 Palbociclib plus letrozole combination after progression on second-line chemotherapy for women with ER/PR-positive high-grade serous or endometrioid ovarian, fallopian tube or peritoneal cancer (LACOG 1018

Subgroup analysis of Brazilian participants of a medical leadership competencies instrument: a cross-sectional survey study of the Latin American Cooperative Oncology Group (LACOG) and the Academy of Leadership Sciences Switzerland (ALSS)